BioMetals

, Volume 24, Issue 6, pp 1045–1057 | Cite as

Acute and chronic metal exposure impairs locomotion activity in Drosophila melanogaster: a model to study Parkinsonism

  • Leonardo Bonilla-Ramirez
  • Marlene Jimenez-Del-Rio
  • Carlos Velez-Pardo
Article

Abstract

The biometals iron (Fe), manganese (Mn) and copper (Cu) have been associated to Parkinson’s disease (PD) and Parkinsonism. In this work, we report for the first time that acute (15 mM for up to 5 days) or chronic (0.5 mM for up to 15 days) Fe, Mn and Cu exposure significantly reduced life span and locomotor activity (i.e. climbing capabilities) in Drosophila melanogaster. It is shown that the concentration of those biometals dramatically increase in Drosophila’s brain acutely or chronically fed with metal. We demonstrate that the metal accumulation in the fly’s head is associated with the neurodegeneration of several dopaminergic neuronal clusters. Interestingly, it is found that the PPL2ab DAergic neuronal cluster was erode by the three metals in acute and chronic metal exposure and the PPL3 DAergic cluster was also erode by the three metals but in acute metal exposure only. Furthermore, we found that the chelator desferoxamine, ethylenediaminetetraacetic acid, and d-penicillamine were able to protect but not rescue D. melanogaster against metal intoxication. Taken together these data suggest that iron, manganese and copper are capable to destroy DAergic neurons in the fly’s brain, thereby impairing their movement capabilities. This work provides for the first time metal-induced Parkinson-like symptoms in D. melanogaster. Understanding therefore the effects of biometals in the Drosophila model may provide insights into the toxic effect of metal ions and more effective therapeutic approaches to Parkinsonism.

Keywords

Copper Drosophila melanogaster Manganese Parkinson Parkinsonism Iron 

References

  1. Atasoy HT, Nuyan O, Tunc T, Yorubulut M, Unal AE, Inan LE (2004) T2-weighted MRI in Parkinson’s disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurol India 52(3):332–337PubMedGoogle Scholar
  2. Au C, Benedetto A, Aschner M (2008) Manganese transport in eukaryotes: the role of DMT1. Neurotoxicology 29(4):569–576PubMedCrossRefGoogle Scholar
  3. Bahadorani S, Bahadorani P, Marcon E, Walker DW, Hilliker AJ (2010) A Drosophila model of Menkes disease reveals a role for DmATP7 in copper absorption and neurodevelopment. Dis Model Mech 3(1–2):84–891PubMedCrossRefGoogle Scholar
  4. Ben-Shachar D, Youdim MBH (1991) Intranigral iron injection induces behavioral and biochemical “Parkinsonism” in rats. J Neurochem 57:2133–2135PubMedCrossRefGoogle Scholar
  5. Berg D (2006) In vivo detection of iron and neuromelanin by transcranial sonography—a new approach for early detection of substantia nigra damage. J Neural Transm 113(6):775–780PubMedCrossRefGoogle Scholar
  6. Brar S, Henderson D, Schenck J, Zimmerman EA (2009) Iron accumulation in the substantia nigra of patients with Alzheimer disease and Parkinsonism. Arch Neurol 66(3):371–374PubMedCrossRefGoogle Scholar
  7. Burke R, Commons E, Camakaris J (2008) Expression and localisation of the essential copper transporter DmATP7 in Drosophila neuronal and intestinal tissues. Int J Biochem Cell Biol 40(9):1850–1860PubMedCrossRefGoogle Scholar
  8. Burton NC, Guilarte TR (2009) Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ Health Perspect 117(3):325–332PubMedCrossRefGoogle Scholar
  9. Cass WA, Grondin R, Andersen AH, Zhang Z, Hardy PA, Hussey-Andersen LK, Rayens WS, Gerhardt GA, Gash DM (2007) Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys. Neurobiol Aging 28(2):258–271PubMedCrossRefGoogle Scholar
  10. Chaudhuri A, Bowling K, Funderburk C, Lawal H, Inamdar A, Wang Z, O’Donnell JM (2007) Interaction of genetic and environmental factors in a Drosophila Parkinsonism model. J Neurosci 27(10):2457–2467PubMedCrossRefGoogle Scholar
  11. Costello DJ, Walsh SL, Harrington HJ, Walsh CH (2004) Concurrent hereditary haemochromatosis and idiopathic Parkinson’s disease: a case report series. J Neurol Neurosurg Psychiatry 75(4):631–633PubMedCrossRefGoogle Scholar
  12. Coulom H, Birman S (2004) Chronic exposure to rotenone models sporadic Parkinson’s disease in Drosophila melanogaster. J Neurosci 24(48):10993–10998PubMedCrossRefGoogle Scholar
  13. Das SK, Ray K (2006) Wilson’s disease: an update. Nat Clin Pract Neurol 2(9):482–493PubMedCrossRefGoogle Scholar
  14. Dexter DT, Jenner P, Schapira AH, Marsden CD (1992) Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson’s Disease Research Group. Ann Neurol 32(Suppl):S94–S100PubMedCrossRefGoogle Scholar
  15. Discalzi G, Pira E, Herrero Hernandez E, Valentini C, Turbiglio M, Meliga F (2000) Occupational Mn Parkinsonism: magnetic resonance imaging and clinical patterns following CaNa2-EDTA chelation. Neurotoxicology 21(5):863–866PubMedGoogle Scholar
  16. Dydak U, Jiang YM, Long LL, Zhu H, Chen J, Li WM, Edden RA, Hu S, Fu X, Long Z, Mo XA, Meier D, Harezlak J, Aschner M, Murdoch JB, Zheng W (2011) In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect 119(2):219–224PubMedCrossRefGoogle Scholar
  17. Egli D, Selvaraj A, Yepiskoposyan H, Zhang B, Hafen E, Georgiev O, Schaffner W (2003) Knockout of ‘metal-responsive transcription factor’ MTF-1 in Drosophila by homologous recombination reveals its central role in heavy metal homeostasis. EMBO J 22(1):100–108PubMedCrossRefGoogle Scholar
  18. Forno LS (1996) Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol 55:259–272PubMedCrossRefGoogle Scholar
  19. Gallez B, Baudelet C, Adline J, Geurts M, Delzenne N (1997) Accumulation of manganese in the brain of mice after intravenous injection of manganese-based contrast agents. Chem Res Toxicol 10(4):360–363PubMedCrossRefGoogle Scholar
  20. Graham JM, Paley MN, Grünewald RA, Hoggard N, Griffiths PD (2000) Brain iron deposition in Parkinson’s disease imaged using the PRIME magnetic resonance sequence. Brain 123(Pt 12):2423–2431PubMedCrossRefGoogle Scholar
  21. Guilarte TR (2010) Manganese and Parkinson’s disease: a critical review and new findings. Environ Health Perspect 118(8):1071–1080PubMedCrossRefGoogle Scholar
  22. Hua H, Georgiev O, Schaffner W, Steiger D (2010) Human copper transporter Ctr1 is functional in Drosophila, revealing a high degree of conservation between mammals and insects. J Biol Inorg Chem 15(1):107–113PubMedCrossRefGoogle Scholar
  23. Huster D (2010) Wilson disease. Best Pract Res Clin Gastroenterol 24(5):531–539PubMedCrossRefGoogle Scholar
  24. Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79(4):368–376PubMedCrossRefGoogle Scholar
  25. Jimenez-Del-Rio M, Velez-Pardo C (2004a) The hydrogen peroxide and its importance in the Alzheimer’s and Parkinson’s disease. Curr Med Chem Cent Nerv Syst Agents 4:279–285CrossRefGoogle Scholar
  26. Jimenez-Del-Rio M, Velez-Pardo C (2004b) Transition metals-induced apoptosis in lymphocytes via hydroxyl radical generation, mitochondria dysfunction and caspase-3 activation: an in vitro model for neurodegeneration. Arch Med Res 35:185–193PubMedCrossRefGoogle Scholar
  27. Jimenez-Del-Rio M, Guzman-Martinez C, Velez-Pardo C (2010) The effects of polyphenols on survival and locomotor activity in Drosophila melanogaster exposed to iron and paraquat. Neurochem Res 35:227–238PubMedCrossRefGoogle Scholar
  28. Kaler SG (2011) ATP7A-related copper transport diseases—emerging concepts and future trends. Nat Rev Neurol 7(1):15–29PubMedCrossRefGoogle Scholar
  29. Kosta P, Argyropoulou MI, Markoula S, Konitsiotis S (2006) MRI evaluation of the basal ganglia size and iron content in patients with Parkinson’s disease. J Neurol 253(1):26–32PubMedCrossRefGoogle Scholar
  30. Lee DW, Andersen JK (2010) Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis? J Neurochem 112(2):332–339PubMedCrossRefGoogle Scholar
  31. Mao Z, Davis RL (2009) Eight different types of dopaminergic neurons innervate the Drosophila mushroom body neuropil: anatomical and physiological heterogeneity. Front Neural Circuits 3:5PubMedCrossRefGoogle Scholar
  32. Martin WR, Wieler M, Gee M (2008) Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70(16 Pt 2):1411–14117PubMedCrossRefGoogle Scholar
  33. Meenakshi-Sundaram S, Mahadevan A, Taly AB, Arunodaya GR, Swamy HS, Shankar SK (2008) Wilson’s disease: a clinico-neuropathological autopsy study. J Clin Neurosci 15(4):409–417PubMedCrossRefGoogle Scholar
  34. Missirlis F, Holmberg S, Georgieva T, Dunkov BC, Rouault TA, Law JH (2006) Characterization of mitochondrial ferritin in Drosophila. Proc Natl Acad Sci USA 103(15):5893–5898PubMedCrossRefGoogle Scholar
  35. Morello M, Zatta P, Zambenedetti P, Martorana A, D’Angelo V, Melchiorri G, Bernardi G, Sancesario G (2007) Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. Brain Res Bull 74(6):406–415PubMedCrossRefGoogle Scholar
  36. Muckenthaler M, Gunkel N, Frishman D, Cyrklaff A, Tomancak P, Hentze MW (1998) Iron-regulatory protein-1 (IRP-1) is highly conserved in two invertebrate species—characterization of IRP-1 homologues in Drosophila melanogaster and Caenorhabditis elegans. Eur J Biochem 254(2):230–237PubMedCrossRefGoogle Scholar
  37. Nakatsuka I, Maeda S, Andoh T, Hayashi Y, Mizuno R, Higuchi H, Miyawaki T (2009) Oxidative changes in the rat brain by intraperitoneal injection of ferric nitrilotriacetate. Redox Rep 14(3):109–114PubMedCrossRefGoogle Scholar
  38. Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM (2007) Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 68(21):1820–1825PubMedCrossRefGoogle Scholar
  39. Olanow CW, Good PF, Shinotoh H, Hewitt KA, Vingerhoets F, Snow BJ, Beal MF, Calne DB, Perl DP (1996) Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 46(2):492–498PubMedGoogle Scholar
  40. Ordoñez-Librado JL, Anaya-Martínez V, Gutierrez-Valdez AL, Colín-Barenque L, Montiel-Flores E, Avila-Costa MR (2010) Manganese inhalation as a Parkinson disease model. Parkinsons Dis 2011:612989PubMedGoogle Scholar
  41. Ozcelik D, Uzun H (2009) Copper intoxication; antioxidant defenses and oxidative damage in rat brain. Biol Trace Elem Res 127(1):45–52PubMedCrossRefGoogle Scholar
  42. Péran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, Celsis P, Rascol O, Démonet JF, Stefani A, Pierantozzi M, Pontieri FE, Caltagirone C, Spalletta G, Sabatini U (2010) Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature. Brain 133(11):3423–3433PubMedCrossRefGoogle Scholar
  43. Perl DP, Olanow CW (2007) The neuropathology of manganese-induced Parkinsonism. J Neuropathol Exp Neurol 66(8):675–682PubMedCrossRefGoogle Scholar
  44. Pienaar IS, Götz J, Feany MB (2010) Parkinson’s disease: insights from non-traditional model organisms. Prog Neurobiol 92(4):558–571PubMedCrossRefGoogle Scholar
  45. Prabhakaran K, Ghosh D, Chapman GD, Gunasekar PG (2008) Molecular mechanism of manganese exposure-induced dopaminergic toxicity. Brain Res Bull 76(4):361–367PubMedCrossRefGoogle Scholar
  46. Rao KV, Norenberg MD (2004) Manganese induces the mitochondrial permeability transition in cultured astrocytes. J Biol Chem 279(31):32333–32338PubMedCrossRefGoogle Scholar
  47. Reddy PV, Rao KV, Norenberg MD (2008) The mitochondrial permeability transition, and oxidative and nitrosative stress in the mechanism of copper toxicity in cultured neurons and astrocytes. Lab Invest 88(8):816–830PubMedCrossRefGoogle Scholar
  48. Salazar J, Mena N, Hunot S, Prigent A, Alvarez-Fischer D, Arredondo M, Duyckaerts C, Sazdovitch V, Zhao L, Garrick LM, Nuñez MT, Garrick MD, Raisman-Vozari R, Hirsch EC (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson’s disease. Proc Natl Acad Sci USA 105(47):18578–18583PubMedCrossRefGoogle Scholar
  49. Salvador GA, Uranga RM, Giusto NM (2010) Iron and mechanisms of neurotoxicity. Int J Alzheimers Dis 2011:720658PubMedGoogle Scholar
  50. Sengstock GJ, Olanow CW, Menzies RA, Dunn AJ, Arendash GW (1993) Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers. J Neurosci Res 35(1):67–82PubMedCrossRefGoogle Scholar
  51. Sengstock GJ, Olanow CW, Dunn AJ, Barone S Jr, Arendash GW (1994) Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra. Exp Neurol 130(1):82–94PubMedCrossRefGoogle Scholar
  52. Shinotoh H, Snow BJ, Hewitt KA, Pate BD, Doudet D, Nugent R, Perl DP, Olanow W, Calne DB (1995) MRI and PET studies of manganese-intoxicated monkeys. Neurology 45(6):1199–1204PubMedGoogle Scholar
  53. Snyder AM, Connor JR (2009) Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta 1790(7):606–614PubMedCrossRefGoogle Scholar
  54. Southon A, Farlow A, Norgate M, Burke R, Camakaris J (2008) Malvolio is a copper transporter in Drosophila melanogaster. J Exp Biol 211(Pt 5):709–716PubMedCrossRefGoogle Scholar
  55. Southon A, Palstra N, Veldhuis N, Gaeth A, Robin C, Burke R, Camakaris J (2010) Conservation of copper-transporting P(IB)-type ATPase function. Biometals 23(4):681–694PubMedCrossRefGoogle Scholar
  56. Spadoni F, Stefani A, Morello M, Lavaroni F, Giacomini P, Sancesario G (2000) Selective vulnerability of pallidal neurons in the early phases of manganese intoxication. Exp Brain Res 135(4):544–551PubMedCrossRefGoogle Scholar
  57. Sriram K, Lin GX, Jefferson AM, Roberts JR, Chapman RS, Chen BT, Soukup JM, Ghio AJ, Antonini JM (2010) Dopaminergic neurotoxicity following pulmonary exposure to manganese-containing welding fumes. Arch Toxicol 84(7):521–540PubMedCrossRefGoogle Scholar
  58. Südmeyer M, Saleh A, Wojtecki L, Cohnen M, Gross J, Ploner M, Hefter H, Timmermann L, Schnitzler A (2006) Wilson’s disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structures. Mov Disord 21(12):2134–2139PubMedCrossRefGoogle Scholar
  59. Takanashi M, Mochizuki H, Yokomizo K, Hattori N, Mori H, Yamamura Y, Mizuno Y (2001) Iron accumulation in the substantia nigra of autosomal recessive juvenile Parkinsonism (ARJP). Parkinsonism Relat Disord 7(4):311–314PubMedCrossRefGoogle Scholar
  60. Taylor RM, Chen Y, Dhawan A, EuroWilson Consortium (2009) Triethylene tetramine dihydrochloride (trientine) in children with Wilson disease: experience at King’s College Hospital and review of the literature. Eur J Pediatr 168(9):1061–1068PubMedCrossRefGoogle Scholar
  61. Tiklová K, Senti KA, Wang S, Gräslund A, Samakovlis C (2010) Epithelial septate junction assembly relies on melanotransferrin iron binding and endocytosis in Drosophila. Nat Cell Biol 12(11):1071–1077PubMedCrossRefGoogle Scholar
  62. Wallis LI, Paley MN, Graham JM, Grünewald RA, Wignall EL, Joy HM, Griffiths PD (2008) MRI assessment of basal ganglia iron deposition in Parkinson’s disease. J Magn Reson Imaging 28(5):1061–1067PubMedCrossRefGoogle Scholar
  63. Yoshiga T, Georgieva T, Dunkov BC, Harizanova N, Ralchev K, Law JH (1999) Drosophila melanogaster transferrin. Cloning, deduced protein sequence, expression during the life cycle, gene localization and up-regulation on bacterial infection. Eur J Biochem 260(2):414–420PubMedCrossRefGoogle Scholar
  64. Youdim MB, Fridkin M, Zheng H (2004) Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson’s disease and other neurodegenerative diseases. J Neural Transm 111(10–11):1455–1471PubMedCrossRefGoogle Scholar
  65. Yu WR, Jiang H, Wang J, Xie JX (2008) Copper (Cu2+) induces degeneration of dopaminergic neurons in the nigrostriatal system of rats. Neurosci Bull 24(2):73–78PubMedCrossRefGoogle Scholar
  66. Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, Giaveri G, Arosio P, Santambrogio P, Fariello RG, Karatekin E, Kleinman MH, Turro N, Hornykiewicz O, Zucca FA (2004) The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci USA 101(26):9843–9848PubMedCrossRefGoogle Scholar
  67. Zecca L, Berg D, Arzberger T, Ruprecht P, Rausch WD, Musicco M, Tampellini D, Riederer P, Gerlach M, Becker G (2005) In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 20(10):1278–1285PubMedCrossRefGoogle Scholar
  68. Zhang J, Zhang Y, Wang J, Cai P, Luo C, Qian Z, Dai Y, Feng H (2010) Characterizing iron deposition in Parkinson’s disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res 1330:124–130PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2011

Authors and Affiliations

  • Leonardo Bonilla-Ramirez
    • 1
  • Marlene Jimenez-Del-Rio
    • 1
  • Carlos Velez-Pardo
    • 1
    • 2
  1. 1.School of Medicine, Medical Research Institute, Neuroscience Research GroupUniversity of Antioquia (UdeA)MedellinColombia
  2. 2.School of Medicine, Medical Research Institute, Neuroscience Research GroupUniversity of Antioquia (UdeA)MedellinColombia

Personalised recommendations